Protai Adds $12 Million To Seed Round - Bringing The Total To $20 Million - To Build An Oncology Drug Discovery Pipeline
Mar 15, 2023•over 2 years ago
Amount Raised
$12 Million
Round Type
seed
Investors
Maj Invest Equity FundPitango Health TechGrove Ventures
Description
Protai, a proteomics and AI-powered drug discovery startup revolutionizing the way new drugs are discovered, today announced that it has added $12 million to its seed round, bringing the total amount to $20M. The round includes existing investors Grove Ventures and Pitango HealthTech and was joined by Copenhagen-based Maj Invest Equity Fund. The additional funding will be used to build Protai's oncology drug discovery pipeline, expand data acquisition as well as increase its discovery activities via pharma partnerships.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech